HotSpot Therapeutics fetches $65m Series B
Boston-based HotSpot Therapeutics, Inc, a biotechnology company, has raised $65 million in Series B financing.
Boston-based HotSpot Therapeutics, Inc, a biotechnology company, has raised $65 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination